Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Hematologic Malignancies Testing Market Be Worth By 2029?

The market size for testing hematologic malignancies has seen a swift expansion in recent years, with a projected growth from $3.16 billion in 2024 to $3.58 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.2%. This growth over the historic timeframe can be linked to an increased frequency of blood cancers, an amplified awareness about early cancer detection, the growing application of flow cytometry and molecular diagnostics, the widening scope of hematology testing within hospitals and laboratories, along with increased provision for reimbursement for cancer diagnostics.

In the coming years, the hematologic malignancies testing market is set to experience significant expansion, with expectations to reach a value of $5.91 billion by 2029, reflecting a compound annual growth rate (CAGR) of 13.3%. Factors such as the surging demand for tailor-made cancer therapies, prevalent use of next-generation sequencing techniques, increased healthcare expenditure in developing markets, advancement of precision oncology initiatives, and escalating number of clinical trials aimed at blood cancer treatments, all combine to drive this growth. The forecast period is also likely to see key developments such as progress in molecular testing methodologies, creation of automated and high-throughput diagnostic infrastructures, continuing research and progress in the field of hematologic malignancies, incorporation of AI technology in test evaluations, and novel introductions in the field of liquid biopsy procedures for blood cancers.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24234&type=smp

Which Key Factors Are Fueling Growth In The Hematologic Malignancies Testing Market?

The growth of the hematologic malignancies testing market appears to correlate with an increase in cancer diagnoses. The process of cancer diagnosis involves various medical tests and evaluations, including imaging, laboratory tests, and biopsies, aimed at confirming the presence of cancer, ascertaining its type and stage. The increase in cancer diagnoses is attributed to better accessibility to screening programs and a surge in public awareness, which leads to earlier detection. Testing for hematologic malignancies aids in diagnosing cancer by facilitating early detection, precise classification, and supervision of blood-related cancers, which further informs targeted treatment plans and enhances patient results. For example, the American Cancer Society, a US-based nonprofit organization, reported that more than 2 million new cancer cases are expected in the US in 2024, marking a 4% increase from prior years. In conclusion, a rise in cancer diagnoses paves the way for growth in the hematologic malignancies testing market.

Which Segmentation Factors Are Critical In The Hematologic Malignancies Testing Market Analysis?

The hematologic malignancies testingmarket covered in this report is segmented –

1) By Test Type: Complete Blood Count (CBC); Flow Cytometry; Molecular Testing; Genetic Testing; Others Test Type

2) By Product: Kits; Services

3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Immunohisto Chemistry (IHC); Cytogenetics; Others Technology

4) By Therapeutic Indication: Leukemia; Lymphoma; Multiple Myeloma; Myeloproliferative Neoplasms; Others Therapeutic Indication

5) By End User: Hospitals; Diagnostic Labs; Academic and Research Institutions; Others End Users

Subsegments:

1) By Complete Blood Count (CBC): Hemoglobin Testing; Hematocrit Measurement; White Blood Cell Count; Red Blood Cell Count; Platelet Count; Mean Corpuscular Volume (MCV); Mean Corpuscular Hemoglobin (MCH)

2) By Flow Cytometry: Immunophenotyping; Cell Cycle Analysis; Apoptosis Detection; Minimal Residual Disease (MRD) Testing; DNA Content Analysis

3) By Molecular Testing: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Reverse Transcriptase-PCR (RT-PCR); Fluorescence In Situ Hybridization (FISH); Microarray Analysis

4) By Genetic Testing: Germline Mutation Testing; Somatic Mutation Testing; Cytogenetic Testing; Chromosomal Aberration Detection; Single Nucleotide Polymorphism (SNP) Analysis

5) By Others Test Type: Bone Marrow Biopsy; Immunohistochemistry (IHC); Enzyme Assays; Serum Protein Electrophoresis (SPEP); Imaging Tests

What Are The Dominant Trends Currently Seen In The Hematologic Malignancies Testing Market?

Leading firms in the hematologic malignancies testing market are aiming to advance pioneering diagnostic methodologies like rapid molecular profiling for more accurate and swift detection, treatment formulation, and tracking of blood cancers. This diagnostic technique evaluates the patient’s genetic structure, revealing any mutations or alterations, thus facilitating more individualized and expedited treatment choices. Case in point, Roswell Park Comprehensive Cancer Center, an all-inclusive cancer center in the US, unveiled PanHeme in November 2023. This novel gene sequencing device is engineered to diagnose hematologic cancers like leukaemia, lymphoma, and multiple myeloma more accurately and rapidly. The test can spot mutations in several hundreds of genes in less than 72 hours, drastically enhancing the speed and accuracy of diagnosis and ultimately leading to more personalized treatment decisions for patients.

Which Players Are Shaping The Competitive Landscape Of The Hematologic Malignancies Testing Market?

Major companies operating in the hematologic malignancies testing market are Johnson & Johnson Private Limited, F. Hoffmann-La Roche Aktiengesellschaft, Merck & Co. Inc., Bayer Aktiengesellschaft, AstraZeneca PLC, Abbott Laboratories, Novartis Aktiengesellschaft, GlaxoSmithKline Public Limited Company, Eli Lilly and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sun Pharmaceutical Industries Limited, Illumina Inc., Bio-Rad Laboratories Inc., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Invitae Corporation, Adaptive Biotechnologies Corporation, Invivoscribe Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hematologic-malignancies-testing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Hematologic Malignancies Testing Market?

North America was the largest region in the hematologic malignancies testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematologic malignancies testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24234&type=smp

Browse Through More Reports Similar to the Global Hematologic Malignancies Testing Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model